Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons

Nature Biotechnology

Volumn 20, Issue 11, 2002, Pages 1103-1110

  Ourednik, Jitka ^a,b,e   Ourednik, Václav ^a,b,e   Lynch, William P ^c   Schachner, Melitta ^a,d   Snyder, Evan Y ^b  

^a SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Northeastern Ohio Medical University   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 (2 METHYLPHENYL)PYRIDINE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 1-METHYL-4-(2'-METHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE; DEXAMPHETAMINE; DRUG DERIVATIVE; TYROSINE 3 MONOOXYGENASE; DOPAMINE; DOPAMINE TRANSPORTER; NEUROPROTECTIVE AGENT;

AGING; ANIMAL; ARTICLE; C57BL MOUSE; CELL COUNT; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONVALESCENCE; DRUG EFFECT; FEMALE; INTOXICATION; MALE; METABOLISM; MOUSE; NERVE CELL; NERVE REGENERATION; PARKINSONISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BRAIN CELL; BRAIN DYSFUNCTION; CELL DAMAGE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOPAMINE RELEASE; HYPOTHESIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY; STRIATE CORTEX;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; AGING; ANIMALS; CELL COUNT; CELL SURVIVAL; DEXTROAMPHETAMINE; FEMALE; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NERVE REGENERATION; NEURONS; PARKINSONIAN DISORDERS; RECOVERY OF FUNCTION; REFERENCE VALUES; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ASSAYS; CELLS; NEUROLOGY;

NEURONS;

BIOTECHNOLOGY;

ANIMALIA; MURINAE;

EID: 0036844019     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt750     Document Type: Article

References (42)

1. Aboody, K.S. et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial tumors. Proc. Natl. Acad. Sci. USA 97, 12846-12851 (2000).
2. Yandava, B.D., Billinghurst, L.L. & Snyder, E.Y. "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc. Natl. Acad. Sci. USA 96, 7029-7034 (1999).
3. Bjorklund, A. & Lindvall, O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3, 537-544 (2000).
4. Snyder, E.Y., Yoon, C., Flax, J.D., & Macklis, J.D. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl. Acad. Sci. USA 94, 11663-11668 (1997).
5. Ourednik, V., Ourednik, J., Park, K.I. & Snyder, E.Y. Neural stem cells - A versatile tool for cell replacement and gene therapy in the central nervous system. Clin. Genet. 56, 267-278 (1999).
6. Snyder, E.Y., Taylor, R.M. & Wolfe, J.H. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374, 367-370 (1995).
7. Grunblatt, E., Mandel, S., Maor, G. & Youdim, M.B.H. Gene expression analysis in N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine. J. Neurochem. 78, 1-12 (2001).
8. Sonsalla, P.K. & Heikkila, R.E. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur. J. Pharmacol. 129, 339-345 (1986).
9. Heikkila, R.E., Hess, A. & Duvoisin, R.C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine in mice. Science 224, 1451-1453 (1984).
10. Gerlach, M. & Riederer, P. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man. J. Neural Transm. 103, 987-1041 (1996).
11. Przedborski, S. & Jackson-Lewis, V. Mechanisms of MPTP toxicity. Mov. Disord. 13 (Suppl. 1), 35-38 (1998).
12. Hamre, K., Tharp, R., Poon, K., Xiong, X. & Smeyne, R.J. Differential strain susceptibility following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: Quantitative analysis in seven strains of Mus musculus. Brain Res. 828, 91-103 (1999).
13. Ourednik, J., Ourednik, W. & Van der Loos, H. Do foetal neural grafts induce repair by the injured juvenile neocortex? Neuroreport 5, 133-136 (1993).
14. Ourednik, J., Ourednik, W. & Mitchell, D.E. Remodeling of lesioned kitten visual cortex after xenotransplantation of fetal mouse neopallium. J. Comp. Neurol. 395, 91-111 (1998).
15. Desai, V.G., Feuers, R.J., Hart, R.W. & Ali, S.F. MPP(+)-induced neurotoxicity in mouse is age-dependent: Evidenced by the selective inhibition of complexes of electron transport. Brain Res. 715, 1-8 (1996).
16. Mandavilli, B.S., Ali, S.F. & Van Houten, B. DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Res. 885, 45-52 (2000).
17. Heikkila, R.E., Sieber, B.A., Manzino, L. & Sonsalla, P.K. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4- phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the mouse. Mol. Chem. Neuropathol. 10, 171-183 (1989).
18. Akerud, P., Canals, J.M., Snyder, E.Y. & Arenas, E. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21, 8108-8118 (2001).
19. Wagner, J. et al. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat. Biotechnol. 17, 653-659 (1999).
20. Rosario, C.M. et al. Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. Development 124, 4213-4224 (1997).
21. Rubio, F.J. et al. BDNF gene transfer to the mammalian brain using CNS-derived neural precursors. Gene Ther. 6, 1851-1866 (1999).
22. Ourednik, V. et al. Segregation of human neural stem cells in the developing primate forebrain. Science 293, 1820-1824 (2001).
23. Ungerstedt, U. & Arbuthnott, G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493 (1970).
24. Kuhar, M.J. Recent biochemical studies of the dopamine transporter - a CNS drug target. Life Sci. 62, 1573-1575 (1998).
25. Barr, M.L. & Bertram, E.G. A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis. Nature 163, 676-677 (1949).
26. Hong, B., Reeves, P., Panning, B., Swanson, M.S. & Yang, T.P. Identification of an autoimmune serum containing antibodies against the Barr body. Proc. Nat. Acad. Sci. USA 98, 8703-8708 (2001).
27. Magavi, S.S., Leavitt, B.R. & Macklis, J.D. Induction of neurogenesis in the neocortex of adult mice. Nature 405, 951-955 (2000).
28. Kordower, J.H. et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773 (2000).
29. Choi-Lundberg, D.L. et al. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838-841 (1997).
30. Studer, L., Tabar, V. & McKay, R.D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1, 290-295 (1998).
31. Storch, A. et al. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol. 170, 317-325 (2001).
32. Bjorklund, L.M. et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 99, 2344-2349 (2002).
33. Martinez-Serrano, A. et al. CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: Complete rescue of axotomized cholinergic neurons after transplantation into the septum. J. Neurosci. 15, 5668-5680 (1995).
34. Bjorklund, A. et al. Towards a neuroprotective gene therapy for Parkinson's disease: Use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model(1). Brain Res. 886, 82-98 (2000).
35. Lowenstein, P.R. & Castro, M.G. Genetic engineering within the adult brain: Implications for molecular approaches to behavioral neuroscience. Physiol. Behav. 73, 833-839 (2001).
36. Ourednik, W. & Ourednik, J. Newly formed host cells in a grafted juvenile neocortex express neurone-specific marker proteins. Neuroreport 5, 1073-1076 (1994).
37. Hodges, H. et al. Conditionally immortal neuroepithelial stem cell grafts reverse age-associated memory impairments in rats. Neuroscience 101, 945-955 (2000).
38. Veizovic, T., Beech, J.S., Stroemer, R.P., Watson, W.P. & Hodges, H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 32, 1012-1019 (2001).
39. Date, I., Notter, M.F., Felten, S.Y. & Felten, D.L. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526, 156-160 (1990).
40. Sidman, R.L., Angevine, J.B., Jr. & Taber-Pierce, E. Atlas of the Mouse Brain and Spinal Cord (Harvard University Press, Cambridge, MA, 1971).
41. Webster, W., Shimada, M. & Langman, J. Effect of fluorodeoxyuridine, colcemid, and bromodeoxyuridine on developing neocortex of the mouse. Am. J. Anal. 137, 67-85 (1973).
42. Cai, L., Hayes, N.L. & Nowakowski, R.S. Local homogeneity of cell cycle length in developing mouse cortex. J. Neurosci. 17, 2079-2087 (1997).